CN Patent
CN106459136B — 一种奥贝胆酸的制备方法
Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2018-06-26 · 8y expired
What this patent protects
提供一种如式(III)所示的化合物及其制备方法,其中R 1 为羟基保护基,优选MOM,以及通过该化合物制备奥贝胆酸的方法。所述制备方法反应条件温和,副产物少,操作简便,适于大规模生产。
USPTO Abstract
提供一种如式(III)所示的化合物及其制备方法,其中R 1 为羟基保护基,优选MOM,以及通过该化合物制备奥贝胆酸的方法。所述制备方法反应条件温和,副产物少,操作简便,适于大规模生产。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.